Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2000 1
2002 1
2006 3
2007 2
2008 3
2009 9
2011 13
2012 7
2013 11
2014 13
2015 20
2016 9
2017 7
2018 9
2019 11
2020 8
2021 7
2022 11
2023 10
2024 11
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Health Technology Assessment del vaccino ricombinante adiuvato contro il virus respiratorio sinciziale (Arexvy®).
Calabrò GE, Rizzo C, Domnich A, DE Waure C, Rumi F, Bonanni P, Boccalini S, Bechini A, Panatto D, Amicizia D, Amodio E, Costantino C, Bert F, Lo Moro G, DI Pietro ML, Giuffrida S, Giordano V, Conversano M, Russo C, Spadea A, Ansaldi F, Grammatico F, Ricciardi R, Torrisi M, Porretta AD, Arzilli G, Scarpaleggia M, Bertola C, Vece M, Lupi C, Lorenzini E, Massaro E, Tocco M, Trapani G, Zarcone E, Munno L, Zace D, Petrella L, Vitale F, Ricciardi W. Calabrò GE, et al. Among authors: panatto d. J Prev Med Hyg. 2024 Jun 30;65(2 Suppl 1):E1-E159. doi: 10.15167/2421-4248/jpmh2024.65.2s1. eCollection 2024 Sep. J Prev Med Hyg. 2024. PMID: 39554593 Free PMC article. Italian. No abstract available.
Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.
Stuurman AL, Carmona A, Biccler J, Descamps A, Levi M, Baum U, Mira-Iglesias A, Bellino S, Hoang U, de Lusignan S, Bonaiuti R, Lina B, Rizzo C, Nohynek H, Díez-Domingo J; DRIVE Study Contributors. Stuurman AL, et al. Front Public Health. 2023 Jul 20;11:1195409. doi: 10.3389/fpubh.2023.1195409. eCollection 2023. Front Public Health. 2023. PMID: 37546295 Free PMC article.
Flucelvax (Optaflu) for seasonal influenza.
Manini I, Domnich A, Amicizia D, Rossi S, Pozzi T, Gasparini R, Panatto D, Montomoli E. Manini I, et al. Among authors: panatto d. Expert Rev Vaccines. 2015 Jun;14(6):789-804. doi: 10.1586/14760584.2015.1039520. Expert Rev Vaccines. 2015. PMID: 25968069 Review.
Neisseria meningitidis B vaccines.
Panatto D, Amicizia D, Lai PL, Gasparini R. Panatto D, et al. Expert Rev Vaccines. 2011 Sep;10(9):1337-51. doi: 10.1586/erv.11.103. Expert Rev Vaccines. 2011. PMID: 21919622 Review.
Meningococcal glycoconjugate vaccines.
Gasparini R, Panatto D. Gasparini R, et al. Among authors: panatto d. Hum Vaccin. 2011 Feb;7(2):170-82. doi: 10.4161/hv.7.2.13717. Epub 2011 Feb 1. Hum Vaccin. 2011. PMID: 21178398 Free PMC article. Review.
Evaluation of the economic burden of Herpes Zoster (HZ) infection.
Panatto D, Bragazzi NL, Rizzitelli E, Bonanni P, Boccalini S, Icardi G, Gasparini R, Amicizia D. Panatto D, et al. Hum Vaccin Immunother. 2015;11(1):245-62. doi: 10.4161/hv.36160. Hum Vaccin Immunother. 2015. PMID: 25483704 Free PMC article.
162 results